Developer docs
API playgroundTry for free, no card

Search company profiles

Oxford Biotrans

Full company profile

uuid0004jgk

Namestring
Oxford Biotrans
Legal namestring
Oxford Biotrans
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Oxford Biotrans is a University of Oxford spin-out founded in 2013 and headquartered in Oxford, United Kingdom. The company develops enzymatic process technologies that produce high-value chemical compounds, applying biocatalysis as an alternative to traditional chemical synthesis routes. Its underlying technology is rooted in proprietary enzyme-based processes derived from academic research at the University of Oxford, and the firm operates as a specialty chemicals / industrial biotechnology business with a small team of 11-50 employees.

The company has raised approximately $7.6M in cumulative equity funding across three disclosed rounds in 2013 (~$970K seed), 2015 (~$3.9M led by Imperial Innovations), and 2017 (~$2.8M led by Touchstone Innovations), with participation from the University of Oxford, Perivoli Innovations, and Oxford Investment Consultants LLP. Leadership comprises founder Luet Wong and CEO Jason King. The firm's business model is consistent with a B2B specialty chemicals model — selling or licensing enzymatic-produced ingredients to industrial customers in sectors such as flavors and fragrances, agrochemicals, or pharmaceuticals — though the input data does not disclose specific products, customers, pricing, or distribution channels. The company's website domain currently appears to be compromised, and primary-source product and commercial details are not available in the provided data, so this description is limited to what the firmographic, funding, and leadership records directly support.

Short descriptiontext

Oxford Biotrans is a University of Oxford spin-out founded in 2013 that develops proprietary enzymatic process technologies to produce high-value chemical compounds for B2B industrial customers. The firm is privately held, based in Oxford, UK, and operates with 11-50 employees.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersOxford, United Kingdom
HQ citystring
Oxford
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
enzymatic process technology, fine chemical manufacturing, biocatalysis solutions, specialty chemical production, green chemistry processes
Industry3 codes
PRIMARYHLAAAJAF
Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYEUAAAIAA
Bio-based Platform & Commodity Chemicals (e.g., bio-ethylene, bio-propylene, bio-BTX, bio-methanol)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYIMAMALAB
Biochemicals & Bio-based Platform Chemicals (cellulose sugars, lignin derivatives, organic acids)
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Specialty Chemicals
Social media profiles1 record
Cost components4 values
Technology or R&D, Personnel, Operations, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Oxford Biotrans is a University of Oxford spin-out that develops enzymatic process technologies to produce high-value chemical compounds. The company applies proprietary biocatalysis methods to convert feedstocks into specialty chemicals used in industrial applications. Its technology platform is built on academic research originating at the University of Oxford.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

No product information available in the provided source data.

Product and service1 record
1High-value chemical compounds via enzymatic processes
CategorySpecialty chemicals
Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Peers10 records
TypeEmerging player
Description

Carbios is a French biotech company using engineered enzymes for plastic recycling and bio-based polymer production. It shares Oxford Biotrans' enzymatic process technology foundation and biomanufacturing orientation, though in a different end market.

TypeOthers
Description

Cargill's bioindustrial business develops and supplies fermentation-derived and enzyme-based ingredients for food, feed, and industrial customers. It is thematically related to Oxford Biotrans through the broader bio-based ingredients value chain and is a potential customer or acquirer.

TypeBroad incumbent
Description

Novozymes is the world's largest industrial enzyme manufacturer, supplying biocatalysts across food, beverage, and chemical industries. It is a broad incumbent with overlapping enzymatic technology, though at a vastly larger scale than Oxford Biotrans.

TypeEmerging player
Description

Ginkgo Bioworks is a US synthetic biology platform that engineers organisms for industrial production of specialty chemicals and ingredients. It is an emerging player with overlapping bioprocess development capabilities serving similar end markets.

TypeDirect peer
Description

Codexis is a US-based enzyme engineering company that develops biocatalysts for pharmaceutical and chemical manufacturing. It is the closest direct peer to Oxford Biotrans given its focus on enzymatic process technology for high-value chemical products.

6Isobionics
TypeDirect peer
Description

Isobionics develops fermentation-based processes for natural flavor and fragrance ingredients. It is directly comparable to Oxford Biotrans in producing bio-based high-value aroma chemicals for the F&F industry.

TypeDirect peer
Description

Amyris uses synthetic biology and fermentation to produce specialty ingredients including flavors, fragrances, and cosmetics materials. It competes with Oxford Biotrans in delivering bio-based high-value compounds to consumer goods customers.

TypeDirect peer
Description

Evolva developed fermentation-based routes to flavor and fragrance ingredients such as nootkatone and resveratrol. It is a direct peer to Oxford Biotrans in the bio-based specialty ingredients space, with overlapping target molecules and customers.

TypeBroad incumbent
Description

DSM has a large bio-based ingredients and specialty chemicals portfolio, including flavors, fragrances, and nutritional ingredients produced via fermentation and biocatalysis. It is a broad incumbent with potential overlap and partnership interest in Oxford Biotrans' technology.

10DuPont Industrial Biosciences
TypeBroad incumbent
Description

DuPont's Industrial Biosciences unit develops enzymes and fermentation processes for chemicals, food, and consumer products. It is a broad incumbent with overlapping enzymatic and bioprocessing capabilities serving similar end-use markets.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Oxford Biotrans

Specialty Chemicalsoxfordbiotrans.com

Oxford Biotrans is a University of Oxford spin-out founded in 2013 that develops proprietary enzymatic process technologies to produce high-value chemical compounds for B2B industrial customers. The firm is privately held, based in Oxford, UK, and operates with 11-50 employees.

What Oxford Biotrans does

Oxford Biotrans is a University of Oxford spin-out founded in 2013 and headquartered in Oxford, United Kingdom. The company develops enzymatic process technologies that produce high-value chemical compounds, applying biocatalysis as an alternative to traditional chemical synthesis routes. Its underlying technology is rooted in proprietary enzyme-based processes derived from academic research at the University of Oxford, and the firm operates as a specialty chemicals / industrial biotechnology business with a small team of 11-50 employees.

The company has raised approximately $7.6M in cumulative equity funding across three disclosed rounds in 2013 (~$970K seed), 2015 (~$3.9M led by Imperial Innovations), and 2017 (~$2.8M led by Touchstone Innovations), with participation from the University of Oxford, Perivoli Innovations, and Oxford Investment Consultants LLP. Leadership comprises founder Luet Wong and CEO Jason King. The firm's business model is consistent with a B2B specialty chemicals model — selling or licensing enzymatic-produced ingredients to industrial customers in sectors such as flavors and fragrances, agrochemicals, or pharmaceuticals — though the input data does not disclose specific products, customers, pricing, or distribution channels. The company's website domain currently appears to be compromised, and primary-source product and commercial details are not available in the provided data, so this description is limited to what the firmographic, funding, and leadership records directly support.

Oxford Biotrans firmographics

Firmographics
Name
Oxford Biotrans
Legal name
Oxford Biotrans
Website
https://oxfordbiotrans.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
1–10 employees
Short description
Oxford Biotrans is a University of Oxford spin-out founded in 2013 that develops proprietary enzymatic process technologies to produce high-value chemical compounds for B2B industrial customers. The firm is privately held, based in Oxford, UK, and operates with 11-50 employees.
Ownership category
akta.pro rank

Oxford Biotrans industry classification

Industry
Product category
Specialty Chemicals
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAAAJAF
Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYEUAAAIAA
Bio-based Platform & Commodity Chemicals (e.g., bio-ethylene, bio-propylene, bio-BTX, bio-methanol)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYIMAMALAB
Biochemicals & Bio-based Platform Chemicals (cellulose sugars, lignin derivatives, organic acids)

Keywords

  • Enzymatic process technology
  • Fine chemical manufacturing
  • Biocatalysis solutions
  • Specialty chemical production
  • Green chemistry processes

Where Oxford Biotrans is headquartered

Location

Headquarters

HQ city
Oxford
HQ country
United Kingdom
HQ region
Europe

Markets served

Oxford Biotrans business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Supply Chain

Oxford Biotrans product offering

Product offering

Core offering

Oxford Biotrans is a University of Oxford spin-out that develops enzymatic process technologies to produce high-value chemical compounds. The company applies proprietary biocatalysis methods to convert feedstocks into specialty chemicals used in industrial applications. Its technology platform is built on academic research originating at the University of Oxford.

Product overview

No product information available in the provided source data.

Differentiator

Problem solved

Functional benefit

Products and services

  • High-value chemical compounds via enzymatic processes

Companies that use Oxford Biotrans

Customer profile

Ideal customer profiles1 record

Oxford Biotrans technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Oxford Biotrans partnerships and signals

Strategic signal

Recent moves3 records

Oxford Biotrans competitors and assessment

Company assessment

Emerging players

  • Carbios: Carbios is a French biotech company using engineered enzymes for plastic recycling and bio-based polymer production. It shares Oxford Biotrans' enzymatic process technology foundation and biomanufacturing orientation, though in a different end market.
  • Ginkgo Bioworks: Ginkgo Bioworks is a US synthetic biology platform that engineers organisms for industrial production of specialty chemicals and ingredients. It is an emerging player with overlapping bioprocess development capabilities serving similar end markets.

Others

  • Cargill: Cargill's bioindustrial business develops and supplies fermentation-derived and enzyme-based ingredients for food, feed, and industrial customers. It is thematically related to Oxford Biotrans through the broader bio-based ingredients value chain and is a potential customer or acquirer.

Broad incumbents

  • Novozymes: Novozymes is the world's largest industrial enzyme manufacturer, supplying biocatalysts across food, beverage, and chemical industries. It is a broad incumbent with overlapping enzymatic technology, though at a vastly larger scale than Oxford Biotrans.
  • DSM (Royal DSM): DSM has a large bio-based ingredients and specialty chemicals portfolio, including flavors, fragrances, and nutritional ingredients produced via fermentation and biocatalysis. It is a broad incumbent with potential overlap and partnership interest in Oxford Biotrans' technology.
  • DuPont Industrial Biosciences: DuPont's Industrial Biosciences unit develops enzymes and fermentation processes for chemicals, food, and consumer products. It is a broad incumbent with overlapping enzymatic and bioprocessing capabilities serving similar end-use markets.

Direct peers

  • Codexis: Codexis is a US-based enzyme engineering company that develops biocatalysts for pharmaceutical and chemical manufacturing. It is the closest direct peer to Oxford Biotrans given its focus on enzymatic process technology for high-value chemical products.
  • Isobionics: Isobionics develops fermentation-based processes for natural flavor and fragrance ingredients. It is directly comparable to Oxford Biotrans in producing bio-based high-value aroma chemicals for the F&F industry.
  • Amyris: Amyris uses synthetic biology and fermentation to produce specialty ingredients including flavors, fragrances, and cosmetics materials. It competes with Oxford Biotrans in delivering bio-based high-value compounds to consumer goods customers.
  • Evolva (now part of ADM): Evolva developed fermentation-based routes to flavor and fragrance ingredients such as nootkatone and resveratrol. It is a direct peer to Oxford Biotrans in the bio-based specialty ingredients space, with overlapping target molecules and customers.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Oxford Biotrans social profiles

Digital presence

Oxford Biotrans financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Oxford Biotrans leadership team

Management profile

Number of profiles

Profiles2 records

Oxford Biotrans funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Oxford Biotrans M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Oxford Biotrans

What does Oxford Biotrans do?

Oxford Biotrans is a University of Oxford spin-out that develops enzymatic process technologies to produce high-value chemical compounds. The company applies proprietary biocatalysis methods to convert feedstocks into specialty chemicals used in industrial applications. Its technology platform is built on academic research originating at the University of Oxford.

Is Oxford Biotrans a public or private company?

Oxford Biotrans is a private company. It is classified as venture growth investor backed and is currently operating.

When was Oxford Biotrans founded?

Oxford Biotrans was founded in 2013. It employs 1 to 10 people.

Where is Oxford Biotrans based?

Oxford Biotrans is headquartered in Oxford, United Kingdom, in the Europe region.

Who are Oxford Biotrans's main competitors?

Emerging players on record are Carbios and Ginkgo Bioworks. Cargill is listed as an others. Broad incumbents are Novozymes, DSM (Royal DSM) and DuPont Industrial Biosciences. Direct peers are Codexis, Isobionics, Amyris and Evolva (now part of ADM).

Does Oxford Biotrans have an API?

No public API is recorded for Oxford Biotrans.

What industry is Oxford Biotrans in?

Oxford Biotrans's product category is Specialty Chemicals. Its primary akta.pro industry code is HLAAAJAF, Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling), with a secondary code of EUAAAIAA, Bio-based Platform & Commodity Chemicals (e.g., bio-ethylene, bio-propylene, bio-BTX, bio-methanol). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales